Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Yumanity, Padlock, CAR-T Fever, & More 12/19/14 Boston
Déjà Vu For Gilman as New Immunology Startup, Padlock, Gets $23M 12/18/14 Boston
With $24M and Pharma Backing, Ex Epizyme Prez Aims to “Raze” Tumors 10/14/14 Boston
Scholar Rock’s Local Approach to Immune Disease Nabs $20M 09/15/14 Boston
Roche To Pay $8.3B For Intermune: Who’s Next In Pulmonary Fibrosis? 08/25/14 San Francisco
East Coast Biotech Roundup: Scholar Rock, Dicerna, Eleven, & More 01/03/14 Boston
Scholar Rock Aims to Hit Disease-Causing Proteins in a “Niche” 01/02/14 Boston
East Coast Biotech Roundup: Moderna, Aileron, Seres, & More 11/22/13 Boston
Don’t Be Naïve: 7 Things to Know Before Taking a Biotech Startup Job 09/16/13 National
Who Should Life Science Pros Follow on Twitter? 09/24/12 National
Biotech Begins to Come of Age on Twitter 09/17/12 National
Genoa Pharma Aims To Satisfy Big Pharma’s Hunger for IPF Drugs 03/30/12 San Diego
Mnemosyne, Hydra, On-Q-ity, & More New England Life Sciences News 02/17/12 Boston
Energy Points, Biogen, Navinet, & More Boston Dealmakers 02/15/12 Boston
Biogen Idec Lets Stromedix Do The Hard Part 02/14/12 Boston
Biogen Buys Stromedix for $75M, Regaining Fibrosis Drug 02/14/12 Boston
Shout Outs for Avila From Polaris, Atlas, & the Twittersphere 01/26/12 Boston
Boston Xconomists and Area Innovators Gather for Special Xconomy Event: The Photos 10/13/11 Boston
Tweetchat on RNA Interference Upstages iPhone (Not Really, but It Was Still Fun) 10/05/11 National
What Most Biotechies Are Missing on Twitter: A Huge Networking Opportunity 09/12/11 National
Why Twitter Matters Now in Biotech, and Why Executives Can’t Ignore it Anymore 06/13/11 National
BayBio’s Annual Conference, Tweet by Tweet 04/22/11 San Francisco
Stromedix Adds Debt to Finance Clinical Trial, Eliza and Google Team Up for Health IT Website, Arsanis Gets $10M, & More Boston-Area Life Sciences News 02/11/11 Boston
Stromedix Chief, After Reloading the Company Treasury, Sets Sight on Trial for Deadly Lung Disease 02/07/11 Boston
$2M Debt Funding for Stromedix 01/26/11 Boston
Hyperion Nails Pivotal Trial, ChemoCentryx Aims High Against Crohn’s, Vivus Shot Down by FDA, & More Bay Area Life Sciences News 11/05/10 San Francisco
Dendreon’s Plan to Meet Demand, Arch Banks on Ikaria IPO, RF Surgical Leaves No Sponge Behind, & More Seattle-Area Life Sciences News 11/04/10 Seattle
How I’ve Discovered Twitter Can Be a Resource, Not a Waste of Time 11/01/10 Boston
Taris Hires New CEO, Stromedix Hopes Clinical Trial Will Advance, Euthymics Hits the Ground With Series A, & More Boston-Area Life Sciences News 07/23/10 Boston
Stromedix, with Biogen Idec Roots, Seeks Exit from Regulatory Limbo 07/20/10 Boston
Page 1 of 2 next page »